News
January 29, 2024: Family advocates distribute lifesaving medicine at Naloxone Hill Day in Washington DC
Family advocates Andrea Thomas and Amy Neville will distribute naloxone at the Dirksen Senate Office Building. The VA will use the NABP’s digital DSCSA platform to help with compliance. Guilty pleas for dark web drug trafficking and manufacturing fake oxycodone, and more.
[...]The Partnership for Safe Medicines supports S. 2943, the SHOP SAFE Act
On January 17, 2024 PSM wrote the Senate Subcommittee on Intellectual Property to endorse S.2934, which would expand the Trademark Act of 1946 to extend liability for selling harmful counterfeits to online platforms. Read the letter here.
[...]January 21, 2024: U.S. Adderall shortages continue to fuel a black market in fake pills
Tests of the counterfeits showed that they were made of many substances, including acetaminophen, duloxetine, caffeine and methamphetamine. Overseas, authorities seized counterfeit pregabalin in Belfast. Pakistan recalled toxic cough syrup. Fake Xanax trafficker Ryan Farace got an additional sentence for money laundering. News about pill presses in five states.
[...]NEW FOIA materials: Contracts with vendors for Florida’s and Colorado’s importation programs
PSM recently published contracts, some obtained via FOIA, with key vendors implementing Colorado’s and Florida’s Canadian drug importation plan. Read them here.
[...]Florida’s October 20, 2023 Section 804 Proposal for the Importation of Prescription Drugs from Canada
Florida’s October 20, 2023 SIP application is the second to last application before FDA approval. The final application was filed on November 16, 2023.
[...]January 8, 2024: DHS reports a surge in pill press seizures
Homeland Security seized over 1,800 pill presses in October and November 2023. The FDA warned Amazon not to sell supplements made with undeclared pharmaceuticals and issued another warning about toxic yellow oleander. More domestic and international news about counterfeit medicine.
[...]Partnership for Safe Medicines Condemns the Weakening of the U.S. Drug Supply through Canadian Drug Importation + Full coverage of decision
PSM’s statement on the FDA decision and full coverage including media stories, official documents, and statements from stakeholders.
[...]FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain
FDA continues to investigate counterfeit Ozempic (semaglutide) injection 1 milligram (mg) in the legitimate U.S. drug supply chain and has seized thousands of units of the product. FDA is aware of five adverse events from this lot.
[...]FDA Alert: Ginseng Compound Recalled for Containing Undeclared Drug Ingredients
This is a reprint of an FDA Alert. 8th Avenue Pharmacy Issues Voluntary Nationwide Recall of Notoginseng Formula Special Gout Granule Due to the Presence of Hidden Drug Ingredients, Diclofenac and Dexamethasone When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does…
[...]December 18, 2023: U.S. seniors are also dying from fentanyl, says Senate report
Overdose deaths among Americans 65 and older quadrupled over the last 20 years. A Brooklyn man pleaded guilty to selling second hand HIV drugs to local pharmacies. The FDA explained “What You Should Know about Eye Drops.” More domestic and global news about counterfeits.
[...]